[divider] Benefits Obtained It favors muscle development and repair due to its high contents of L-Carnitine Increased resilience to fatigue, improved performance and reduced recovery time after exercise, due to its abundant natural antioxidants, required for mitochondrial metabolism Reduced lactic acid production in muscles and blood during exercise, avoiding cramps, numbness and acidosis due to its high contents of Omega-3 fatty acids (clean energy) Enhanced inflammatory response, strengthened immunity and reduced bleeding (EP) due to its high contents of Omega-3 fatty acids (Alpha-linolenic Acid) [divider] Dosage In high performance or severely injured horses the advised dosage is 150 to 400 cc according to the athletes condition, size, level of training and/or effort (or as directed by the veterinarian) [divider] Ingredients Alpha-linolenic Acid Omega-3 fatty acids (more than 67 % of total fat) L-Carnitine [divider] Usage It may be administered either with food or orally with syringe
Joe Rogans public mention of using BPC-157 for tennis elbow brought wider attention to the compound, sparking interest across various combat sports disciplines
LR-3 IGF-1 Application: -average 14% of fat decrease -average 8.8% increase the structures of the body and lean muscle -Improved skin texture resulting in a more youthful appearance -Remove the wrinkles from skin -Increased bone density, stopped osteoporosis -Faster healing of any type of injury, fracture, or wound -Significantly increased immunity and resistance to infection -Increased brain function, retention of intellect with aging -Improvement of Alzheimer and Parkinson syndromes -Improved sex drive -The improvement in the fullest physical and mental well-being -Improved training tolerance -Improved mood, less depression and fatigue -Improved heart and kidney function -Large cardiac output -Cellulite disappearing -Cartilage regeneration Indication: -Body building -Anti aging -Fat Loss -Get taller -Any cases of diabetes IGF-1 LR3 Specification: Why use IGF-1
Side effects are rare and mild
The other authors report no conflicts of interest.
